These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8542606)

  • 1. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans serotype C as determined by 2D 1H NMR spectroscopy.
    Bacon BE; Cherniak R
    Carbohydr Res; 1995 Oct; 276(2):365-86. PubMed ID: 8542606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy.
    Bacon BE; Cherniak R; Kwon-Chung KJ; Jacobson ES
    Carbohydr Res; 1996 Mar; 283():95-110. PubMed ID: 8901265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the 13C-enriched O-deacetylated glucuronoxylomannan of Cryptococcus neoformans serotype A determined by NMR spectroscopy.
    Sheng S; Cherniak R
    Carbohydr Res; 1997 Jun; 301(1-2):33-40. PubMed ID: 9228737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy.
    Turner SH; Cherniak R; Reiss E; Kwon-Chung KJ
    Carbohydr Res; 1992 Sep; 233():205-18. PubMed ID: 1446309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis.
    Cherniak R; Morris LC; Belay T; Spitzer ED; Casadevall A
    Infect Immun; 1995 May; 63(5):1899-905. PubMed ID: 7729900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucuronoxylomannan of Cryptococcus neoformans serotype B: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy.
    Turner SH; Cherniak R
    Carbohydr Res; 1991 Apr; 211(1):103-16. PubMed ID: 1773425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete assignment of the 1H- and 13C-n.m.r. spectra of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans serotype B.
    Skelton MA; van Halbeek H; Cherniak R
    Carbohydr Res; 1991 Dec; 221():259-68. PubMed ID: 1816923
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure determination of Cryptococcus neoformans serotype A-variant glucuronoxylomannan by 13C-n.m.r. spectroscopy.
    Cherniak R; Jones RG; Reiss E
    Carbohydr Res; 1988 Jan; 172(1):113-38. PubMed ID: 3280130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure of a
    Hargett AA; Azurmendi HF; Crawford CJ; Wear MP; Oscarson S; Casadevall A; Freedberg DI
    Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2315733121. PubMed ID: 38330012
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of a hexasaccharide, the repeating unit of O-deacetylated GXM of C. neoformans serotype A.
    Zhang J; Kong F
    Carbohydr Res; 2003 Aug; 338(17):1719-25. PubMed ID: 12892938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans.
    McFadden DC; Fries BC; Wang F; Casadevall A
    Eukaryot Cell; 2007 Aug; 6(8):1464-73. PubMed ID: 17601878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facile synthesis of the heptasaccharide repeating unit of O-deacetylated GXM of C. neoformans serotype B.
    Zhao W; Kong F
    Bioorg Med Chem; 2005 Jan; 13(1):121-30. PubMed ID: 15582457
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Kuttel MM; Casadevall A; Oscarson S
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32517333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural studies of the capsular polysaccharide of a non-neoformans Cryptococcus species identified as C. laurentii, which was reclassified as Cryptococcus flavescens, from a patient with AIDS.
    Ikeda R; Maeda T
    Carbohydr Res; 2004 Feb; 339(3):503-9. PubMed ID: 15013387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-polysaccharide interactions. A monoclonal antibody specific for the capsular polysaccharide of Cryptococcus neoformans.
    Otteson EW; Welch WH; Kozel TR
    J Biol Chem; 1994 Jan; 269(3):1858-64. PubMed ID: 8294434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies.
    Todaro-Luck F; Reiss E; Cherniak R; Kaufman L
    Infect Immun; 1989 Dec; 57(12):3882-7. PubMed ID: 2680986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay.
    Belay T; Cherniak R
    Infect Immun; 1995 May; 63(5):1810-9. PubMed ID: 7537249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected diversity in the fine specificity of monoclonal antibodies that use the same V region gene to glucuronoxylomannan of Cryptococcus neoformans.
    McFadden DC; Casadevall A
    J Immunol; 2004 Mar; 172(6):3670-7. PubMed ID: 15004170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network.
    Cherniak R; Valafar H; Morris LC; Valafar F
    Clin Diagn Lab Immunol; 1998 Mar; 5(2):146-59. PubMed ID: 9521136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of a heptasaccharide fragment of the O-deacetylated GXM of C. neoformans serotype C.
    Zhao W; Kong F
    Carbohydr Res; 2005 Jul; 340(10):1673-81. PubMed ID: 15927170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.